These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9230825

  • 1. Latanoprost and physostigmine have mostly additive ocular hypotensive effects in human eyes.
    Lindén C, Alm A.
    Arch Ophthalmol; 1997 Jul; 115(7):857-61. PubMed ID: 9230825
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes.
    Serle JB, Podos SM, Kitazawa Y, Wang RF.
    Jpn J Ophthalmol; 1998 Jul; 42(2):95-100. PubMed ID: 9587840
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.
    Maus TL, Nau C, Brubaker RF.
    Arch Ophthalmol; 1999 May; 117(5):586-91. PubMed ID: 10326954
    [Abstract] [Full Text] [Related]

  • 6. Effect of pilocarpine 4% in combination with latanoprost 0.005% or 8-iso prostaglandin E2 0.1% on intraocular pressure in laser-induced glaucomatous monkey eyes.
    Serle JB, Wang RF, Mittag TW, Shen F, Podos SM.
    J Glaucoma; 2001 Jun; 10(3):215-9. PubMed ID: 11442186
    [Abstract] [Full Text] [Related]

  • 7. Physostigmine increases aqueous humor production in human eyes.
    Lindén C, Alm A.
    Curr Eye Res; 1997 Nov; 16(11):1166-70. PubMed ID: 9395778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment.
    Johnson TV, Fan S, Zhan G, Camras CB, Toris CB.
    J Glaucoma; 2010 Aug; 19(6):356-64. PubMed ID: 20179619
    [Abstract] [Full Text] [Related]

  • 12. Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes.
    Geyer O, Man O, Weintraub M, Silver DM.
    Am J Ophthalmol; 2001 Feb; 131(2):198-202. PubMed ID: 11228295
    [Abstract] [Full Text] [Related]

  • 13. Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye.
    Sponsel WE, Mensah J, Kiel JW, Remky A, Trigo Y, Baca W, Friberg T.
    Am J Ophthalmol; 2000 Aug; 130(2):151-9. PubMed ID: 11004288
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
    Quaranta L, Gandolfo F, Turano R, Rovida F, Pizzolante T, Musig A, Gandolfo E.
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Maintained intraocular pressure reduction with once-a-day application of a new prostaglandin F2 alpha analogue (PhXA41). An in-hospital, placebo-controlled study.
    Rácz P, Ruzsonyi MR, Nagy ZT, Bito LZ.
    Arch Ophthalmol; 1993 May; 111(5):657-61. PubMed ID: 8489449
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.